122 related articles for article (PubMed ID: 30977120)
1. SET domain containing 1B gene is mutated in primary hepatic neuroendocrine tumors.
Yang P; Huang X; Lai C; Li L; Li T; Huang P; Ouyang S; Yan J; Cheng S; Lei G; Wang Z; Yu L; Hong Z; Li R; Dong H; Wang C; Yu Y; Wang X; Li X; Wang L; Lv F; Yin Y; Yang H; Song J; Gao Q; Wang X; Zhang S
Int J Cancer; 2019 Dec; 145(11):2986-2995. PubMed ID: 30977120
[TBL] [Abstract][Full Text] [Related]
2. Molecular deciphering of primary liver neuroendocrine neoplasms confirms their distinct existence with foregut-like profile.
de Mestier L; Nicolle R; Poté N; Rebours V; Cauchy F; Hentic O; Maire F; Ronot M; Lebtahi R; Sauvanet A; Paradis V; Ruszniewski P; Couvelard A; Cros J
J Pathol; 2022 Sep; 258(1):58-68. PubMed ID: 35681273
[TBL] [Abstract][Full Text] [Related]
3. The mutational landscape and prognostic indicators of pseudomyxoma peritonei originating from the ovary.
Wang B; Yao J; Ma R; Liu D; Lu Y; Shi G; An L; Xia A; Chen F; Pang S; Zhai X; Liu G; Chen S; Xu M; Song L; Xu H
Int J Cancer; 2021 Apr; 148(8):2036-2047. PubMed ID: 33403690
[TBL] [Abstract][Full Text] [Related]
4. Cervical small cell neuroendocrine tumor mutation profiles via whole exome sequencing.
Cho SY; Choi M; Ban HJ; Lee CH; Park S; Kim H; Kim YS; Lee YS; Lee JY
Oncotarget; 2017 Jan; 8(5):8095-8104. PubMed ID: 28042953
[TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine carcinoma and mixed neuroendocrine‒non-neuroendocrine neoplasm of the stomach: a clinicopathological and exome sequencing study.
Ishida S; Akita M; Fujikura K; Komatsu M; Sawada R; Matsumoto H; Saegusa J; Itoh T; Kakeji Y; Zen Y
Hum Pathol; 2021 Apr; 110():1-10. PubMed ID: 33359239
[TBL] [Abstract][Full Text] [Related]
6. Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas.
Ding X; He M; Chan AWH; Song QX; Sze SC; Chen H; Man MKH; Man K; Chan SL; Lai PBS; Wang X; Wong N
Gastroenterology; 2019 Dec; 157(6):1630-1645.e6. PubMed ID: 31560893
[TBL] [Abstract][Full Text] [Related]
7. High‑level SETD1B gene expression is associated with unfavorable prognosis in hepatocellular carcinoma.
Chen D; Li T; Wang C; Lei G; Wang R; Wang Z; Yu L; Yan J; Zhang P; Wang X; Zhang S; Yang P
Mol Med Rep; 2019 Mar; 19(3):1587-1594. PubMed ID: 30628696
[TBL] [Abstract][Full Text] [Related]
8. Cystic Primary Hepatic Neuroendocrine Tumor.
Kim JM; Lee WA; Shin HD; Song IH; Kim SB
Korean J Gastroenterol; 2021 Nov; 78(5):300-304. PubMed ID: 34824189
[TBL] [Abstract][Full Text] [Related]
9.
Sakthikumar S; Elvers I; Kim J; Arendt ML; Thomas R; Turner-Maier J; Swofford R; Johnson J; Schumacher SE; Alföldi J; Axelsson E; Couto CG; Kisseberth WC; Pettersson ME; Getz G; Meadows JRS; Modiano JF; Breen M; Kierczak M; Forsberg-Nilsson K; Marinescu VD; Lindblad-Toh K
Cancer Res; 2018 Jul; 78(13):3421-3431. PubMed ID: 29724721
[TBL] [Abstract][Full Text] [Related]
10. Frameshift mutation of a histone methylation-related gene SETD1B and its regional heterogeneity in gastric and colorectal cancers with high microsatellite instability.
Choi YJ; Oh HR; Choi MR; Gwak M; An CH; Chung YJ; Yoo NJ; Lee SH
Hum Pathol; 2014 Aug; 45(8):1674-81. PubMed ID: 24925220
[TBL] [Abstract][Full Text] [Related]
11. De novo variants in SETD1B are associated with intellectual disability, epilepsy and autism.
Hiraide T; Nakashima M; Yamoto K; Fukuda T; Kato M; Ikeda H; Sugie Y; Aoto K; Kaname T; Nakabayashi K; Ogata T; Matsumoto N; Saitsu H
Hum Genet; 2018 Jan; 137(1):95-104. PubMed ID: 29322246
[TBL] [Abstract][Full Text] [Related]
12. The Genetic Basis of Hepatosplenic T-cell Lymphoma.
McKinney M; Moffitt AB; Gaulard P; Travert M; De Leval L; Nicolae A; Raffeld M; Jaffe ES; Pittaluga S; Xi L; Heavican T; Iqbal J; Belhadj K; Delfau-Larue MH; Fataccioli V; Czader MB; Lossos IS; Chapman-Fredricks JR; Richards KL; Fedoriw Y; Ondrejka SL; Hsi ED; Low L; Weisenburger D; Chan WC; Mehta-Shah N; Horwitz S; Bernal-Mizrachi L; Flowers CR; Beaven AW; Parihar M; Baseggio L; Parrens M; Moreau A; Sujobert P; Pilichowska M; Evens AM; Chadburn A; Au-Yeung RK; Srivastava G; Choi WW; Goodlad JR; Aurer I; Basic-Kinda S; Gascoyne RD; Davis NS; Li G; Zhang J; Rajagopalan D; Reddy A; Love C; Levy S; Zhuang Y; Datta J; Dunson DB; Davé SS
Cancer Discov; 2017 Apr; 7(4):369-379. PubMed ID: 28122867
[TBL] [Abstract][Full Text] [Related]
13. Genes involved in angiogenesis and mTOR pathways are frequently mutated in Asian patients with pancreatic neuroendocrine tumors.
Chou WC; Lin PH; Yeh YC; Shyr YM; Fang WL; Wang SE; Liu CY; Chang PM; Chen MH; Hung YP; Li CP; Chao Y; Chen MH
Int J Biol Sci; 2016; 12(12):1523-1532. PubMed ID: 27994516
[No Abstract] [Full Text] [Related]
14. Whole Exome Sequencing of Ulcerative Colitis-associated Colorectal Cancer Based on Novel Somatic Mutations Identified in Chinese Patients.
Yan P; Wang Y; Meng X; Yang H; Liu Z; Qian J; Zhou W; Li J
Inflamm Bowel Dis; 2019 Jul; 25(8):1293-1301. PubMed ID: 30794281
[TBL] [Abstract][Full Text] [Related]
15. Primary hepatic neuroendocrine tumour with multiple liver metastases: A case report with literature review.
Yu WM; Li R; Sun BL; Du JK; Tuo HF
Int J Surg Case Rep; 2021 Dec; 89():106590. PubMed ID: 34784532
[TBL] [Abstract][Full Text] [Related]
16. Activating mutations in PTPN3 promote cholangiocarcinoma cell proliferation and migration and are associated with tumor recurrence in patients.
Gao Q; Zhao YJ; Wang XY; Guo WJ; Gao S; Wei L; Shi JY; Shi GM; Wang ZC; Zhang YN; Shi YH; Ding J; Ding ZB; Ke AW; Dai Z; Wu FZ; Wang H; Qiu ZP; Chen ZA; Zhang ZF; Qiu SJ; Zhou J; He XH; Fan J
Gastroenterology; 2014 May; 146(5):1397-407. PubMed ID: 24503127
[TBL] [Abstract][Full Text] [Related]
17. Primary hepatic neuroendocrine tumor with multiple liver metastases: A case report with literature review.
Xia Y; Zhang L; Wu H; Qiao L; Xia L
J Int Med Res; 2020 Jun; 48(6):300060520932114. PubMed ID: 32589085
[TBL] [Abstract][Full Text] [Related]
18. Exome-level comparison of primary well-differentiated neuroendocrine tumors and their cell lines.
Boora GK; Kanwar R; Kulkarni AA; Pleticha J; Ames M; Schroth G; Beutler AS; Banck MS
Cancer Genet; 2015; 208(7-8):374-81. PubMed ID: 26087898
[TBL] [Abstract][Full Text] [Related]
19. Identification of the BRAF V600E mutation in gastroenteropancreatic neuroendocrine tumors.
Park C; Ha SY; Kim ST; Kim HC; Heo JS; Park YS; Lauwers G; Lee J; Kim KM
Oncotarget; 2016 Jan; 7(4):4024-35. PubMed ID: 26684240
[TBL] [Abstract][Full Text] [Related]
20. Whole-exome mutational landscape of neuroendocrine carcinomas of the gallbladder.
Liu F; Li Y; Ying D; Qiu S; He Y; Li M; Liu Y; Zhang Y; Zhu Q; Hu Y; Liu L; Li G; Pan W; Jin W; Mu J; Cao Y; Liu Y
Signal Transduct Target Ther; 2021 Feb; 6(1):55. PubMed ID: 33563892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
